Advisory Practice

Board-level strategy and governance for dental businesses, investors and the technology businesses that serve them.

Independent advisory rooted in fifteen years of operating experience inside UK dental.

Andy is not a dentist. He arrived in the sector in 2011 from banking, via accountancy and hospitality, and spent fifteen years at the commercial centre of UK dental consolidation.

That career included more than 120 acquisitions, two PE transactions, and senior leadership roles at Henry Schein, Portman Dental Care and Agilio Software. He has sat on both sides of acquisition tables and on the deal team for two private equity transactions inside the UK's most complex healthcare market.

Andy now advises the people who are building, investing in, and transforming UK dental.

15+

Years in UK dental

120+

Dental acquisitions

2

Institutional PE transactions

11

European markets

Engagement Types

How Andy works with clients.

01 · Service

Non-Executive Director and Board Adviser

For dental groups, DSOs and healthcare technology businesses that need independent board-level input on strategy, governance and M&A.

Andy works with businesses at inflection points. Preparing for investment. Navigating a transaction. Building the governance infrastructure required for the next stage of growth. Managing the complexity that arrives with rapid consolidation.

What Andy brings to a board:

  • –A track record across 120+ acquisitions and two institutional PE transactions
  • –Deep understanding of UK dental governance, CQC, and the compliance layer that trips up fast-growing groups
  • –Independence from the executive team, and the willingness to ask the questions that stop being asked in rooms full of operational expertise
  • –A network across PE, M&A advisory, dental media and the DSO leadership community

Typical engagements run on a retained basis. Andy holds a small number of seats and is selective.

Who this is for

PE-backed dental groups, independently-owned DSOs at 10+ sites, and healthcare technology businesses with UK dental as a primary market.

02 · Service

Strategic Advisory: Market Entry, Growth and Transactions

For investors and technology businesses that need a knowledgeable, independent guide to the UK dental market.

UK dental is not one market. It is three: NHS, private, and corporate consolidation. Each has different economics, different governance requirements, different buyer behaviour. Most technology businesses and international investors misread it on entry. That misreading is expensive.

Andy provides:

  • –UK market entry strategy for dental and healthcare technology businesses
  • –Sector intelligence and deal origination for PE firms and investors active in dental
  • –Pre-transaction governance and capital readiness assessments for groups preparing for investment or sale
  • –Advisory board roles for technology businesses entering the UK dental market

Engagements are structured as fixed-fee projects or retained advisory, depending on scope.

Who this is for

PE firms and investors assessing dental or healthcare technology assets. International SaaS and technology businesses entering the UK dental market. Dental groups preparing for a transaction.

03 · Service

UK Compliance Audit: Healthcare Technology

A fixed-scope diagnostic for healthcare technology businesses entering UK dental who need a clear, credible compliance narrative before approaching group-level buyers.

The UK operates a significantly more complex regulatory environment than North America or mainland Europe for dental technology. GDPR, CQC readiness, NHS data security standards, Software as a Medical Device classification, and clinical safety standards under DCB0129 and DCB0160: group procurement teams will ask about all of them. Single-site early adopters will not.

Getting this wrong at the wrong moment costs deals.

A compliance audit from Sloan Strategic Advisory gives you:

  • –A gap analysis across all relevant UK regulatory frameworks
  • –A credible compliance narrative for use in sales, procurement and investor conversations
  • –A prioritised remediation roadmap with clear ownership and timelines
  • –Positioning guidance for CQC-regulated buyers

Fixed fee engagement. Delivered within 6–8 weeks.

Who this is for

International dental technology businesses preparing for UK market entry; SaaS businesses with NHS-adjacent products; AI health technology platforms entering the UK dental sector.

Let's talk.

If you are building, investing in, or advising a dental business and want to understand whether there is a fit, the first conversation is straightforward.

Thinking about selling or valuing a practice? Read what your dental practice is actually worth.

Andy Sloan, Founder, Sloan Strategic Advisory

Credentials.

  • –Founder, Sloan Strategic Advisory
  • –Divisional Strategic Chair, Dental, Agilio Software
  • –Previously: Managing Director, Dental EMEA, Agilio Software
  • –120+ dental acquisitions across PE-backed businesses
  • –Two institutional PE transactions
  • –Senior leadership: Henry Schein, Portman Dental Care
  • –Executive Editor (Dental), Dentist Times
  • –Chair, DentalForum EMEA 2026
  • –Author, The Accidental Dental Strategist (forthcoming)
  • –Advisory Board, Marea Software Inc. (Valsoft)
  • –Adviser, Ark Dentistry
  • –Adviser, Glo Aligners
  • –Adviser, MANI Medical Germany
  • –Non-Executive Director, Casa Dental Group